Biopharma firms must diversify CDMO partnerships to avoid costly delays: Shilpa Biologicals MD
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
Madhav Bhutada says overdependence on large CDMOs and delayed engagement can increase development costs by up to 40% and slow clinical progress
The company highlighted continued demand strength and pricing resilience despite global disruptions
The move signals a major expansion milestone for the Swiss laboratory automation company
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives
In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
POSEIDON is among the largest global datasets to quantify this residual inflammatory burden
The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
The new facility marks Align’s first manufacturing presence in India and its fourth globally
Subscribe To Our Newsletter & Stay Updated